All News #Library
Biotech
Storm secures $56M series C, launches ph. 2 sarcoma trial
16 Apr 2026 //
GLOBENEWSWIRE
STORM Therapeutics, AlidaBio Target RNA in Cancer Therapies
08 Jan 2026 //
PHARMIWEB
STORM Appoints Dr. Martin as Chief Development Officer
26 Jun 2025 //
PR NEWSWIRE
Coherus & Storm therapeutics to Test STC-15 + LOQTORZI in Combo
27 May 2025 //
GLOBENEWSWIRE
Storm Therapeutics Presents Data on METTL3 Inhibitor at SITC
11 Nov 2024 //
PR NEWSWIRE
STORM`s METTL3 Inhibitor STC-15 Interim Phase 1 Data At ASCO
03 Jun 2024 //
PR NEWSWIRE
STORM`s to Present Ph1 Data on its METTL3 RNA Methyltransferase Inh. STC-15
24 May 2024 //
PHARMIWEB
Storm Stc-15 Interim Phase 1: Asco 2024 Mettl3 Rna Methyltransferase
24 May 2024 //
PR NEWSWIRE
STORM Therapeutics Presented Novel Pre-Clinical Data on STC-15
17 Oct 2023 //
PR NEWSWIRE

Market Place
Sourcing Support